HUNTSWORTH acquired by CLAYTON, DUBILIER & RICE (CD&R)

Huntsworth is an international healthcare and communications group headquartered in London, providing a broad portfolio of specialty services that support the commercialization and lifecycle management of pharmaceutical and biotechnology products. The group’s core focus is its Health division, which delivers medical affairs, market access, and integrated marketing and communications services to large and mid‑size pharma and biotech companies across the US and Europe. Over the past decade, Huntsworth has transformed from a traditional communications agency into a diversified pharma commercialization services platform, with around 85% of the group’s operating profit now generated by its Health business. The company operates through a global network of 46 offices in about 20 countries, employing approximately 2,000 people, and offers end‑to‑end support for product launches, stakeholder engagement, and ongoing commercial execution. Its Health segment includes medical communications, scientific and regulatory advisory, market access strategy, and tailored marketing campaigns, all designed to help clients navigate complex regulatory environments, build evidence‑based value propositions, and drive uptake of innovative therapies. This specialist positioning makes Huntsworth a preferred partner for companies developing increasingly sophisticated, high‑value drug portfolios.